{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T06:22:47Z","timestamp":1790317367171,"version":"4.1.0"},"reference-count":25,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2015,2,1]],"date-time":"2015-02-01T00:00:00Z","timestamp":1422748800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["redjournal.org","clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Radiation Oncology*Biology*Physics"],"published-print":{"date-parts":[[2015,2]]},"DOI":"10.1016\/j.ijrobp.2014.10.027","type":"journal-article","created":{"date-parts":[[2015,1,15]],"date-time":"2015-01-15T18:31:01Z","timestamp":1421346661000},"page":"268-276","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":29,"title":["Impact of 1p\/19q Codeletion and Histology on Outcomes of Anaplastic Gliomas Treated With Radiation Therapy and Temozolomide"],"prefix":"10.1016","volume":"91","clinical-trial-number":[{"clinical-trial-number":"nct00626990","registry":"10.18810\/clinical-trials-gov"},{"clinical-trial-number":"nct00887146","registry":"10.18810\/clinical-trials-gov"}],"author":[{"given":"Christina K.","family":"Speirs","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6826-908X","authenticated-orcid":false,"given":"Joseph R.","family":"Simpson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1399-9904","authenticated-orcid":false,"given":"Clifford G.","family":"Robinson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Todd A.","family":"DeWees","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David D.","family":"Tran","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gerry","family":"Linette","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael R.","family":"Chicoine","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ralph G.","family":"Dacey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Keith M.","family":"Rich","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joshua L.","family":"Dowling","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eric C.","family":"Leuthardt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gregory J.","family":"Zipfel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Albert H.","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5153-506X","authenticated-orcid":false,"given":"Jiayi","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijrobp.2014.10.027_bib1","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1093\/neuonc\/not027","article-title":"1p\/19q codeletion and IDH1\/2 mutation identified a subtype of anaplastic oligoastrocytomas with prognosis as favorable as anaplastic oligodendrogliomas","volume":"15","author":"Jiang","year":"2013","journal-title":"Neuro Oncol"},{"key":"10.1016\/j.ijrobp.2014.10.027_bib2","doi-asserted-by":"crossref","first-page":"1246","DOI":"10.1200\/JCO.2005.04.9874","article-title":"Current strategies in treatment of oligodendroglioma: Evolution of molecular signatures of response","volume":"24","author":"Jaeckle","year":"2006","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ijrobp.2014.10.027_bib3","first-page":"839","article-title":"Molecular subtypes of anaplastic oligodendroglioma: Implications for patient management at diagnosis","volume":"7","author":"Ino","year":"2001","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.ijrobp.2014.10.027_bib4","doi-asserted-by":"crossref","first-page":"2707","DOI":"10.1200\/JCO.2005.04.3414","article-title":"Phase III trial of chemotherapy plus radiotherapy compared with radiotherapy alone for pure and mixed anaplastic oligodendroglioma: Intergroup Radiation Therapy Oncology Group Trial 9402","volume":"24","author":"Cairncross","year":"2006","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ijrobp.2014.10.027_bib5","doi-asserted-by":"crossref","first-page":"2715","DOI":"10.1200\/JCO.2005.04.6078","volume":"24","author":"van den Bent","year":"2006","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ijrobp.2014.10.027_bib6","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1200\/JCO.2012.43.2674","article-title":"Phase III trial of chemoradiotherapy for anaplastic oligodendroglioma: Long-term results of RTOG 9402","volume":"31","author":"Cairncross","year":"2013","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ijrobp.2014.10.027_bib7","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1200\/JCO.2012.43.2229","article-title":"Adjuvant procarbazine, lomustine, and vincristine chemotherapy in newly diagnosed anaplastic oligodendroglioma: Long-term follow-up of EORTC brain tumor group study 26951","volume":"31","author":"Van den Bent","year":"2013","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ijrobp.2014.10.027_bib8","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1016\/S1470-2045(09)70025-7","article-title":"Effects of radiotherapy with concomitant and adjuvant temozolomide versus radiotherapy alone on survival in glioblastoma in a randomised phase III study: 5-Year analysis of the EORTC-NCIC trial","volume":"10","author":"Stupp","year":"2009","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.ijrobp.2014.10.027_bib9","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1056\/NEJMoa043330","article-title":"Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma","volume":"352","author":"Stupp","year":"2005","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ijrobp.2014.10.027_bib10","doi-asserted-by":"crossref","first-page":"2762","DOI":"10.1200\/JCO.1999.17.9.2762","article-title":"Multicenter phase II trial of temozolomide in patients with anaplastic astrocytoma or anaplastic oligoastrocytoma at first relapse. Temodal Brain Tumor Group","volume":"17","author":"Yung","year":"1999","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ijrobp.2014.10.027_bib11","doi-asserted-by":"crossref","first-page":"2305","DOI":"10.1200\/JCO.2003.12.097","article-title":"Phase II evaluation of temozolomide and 13-cis-retinoic acid for the treatment of recurrent and progressive malignant glioma: A North American Brain Tumor Consortium study","volume":"21","author":"Jaeckle","year":"2003","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ijrobp.2014.10.027_bib12","doi-asserted-by":"crossref","first-page":"4746","DOI":"10.1200\/JCO.2006.06.3891","article-title":"Correlations between O6-methylguanine DNA methyltransferase promoter methylation status, 1p and 19q deletions, and response to temozolomide in anaplastic and recurrent oligodendroglioma: A prospective GICNO study","volume":"24","author":"Brandes","year":"2006","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ijrobp.2014.10.027_bib13","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1093\/neuonc\/nor040","article-title":"International retrospective study of over 1000 adults with anaplastic oligodendroglial tumors","volume":"13","author":"Lassman","year":"2011","journal-title":"Neuro Oncol"},{"key":"10.1016\/j.ijrobp.2014.10.027_bib14","doi-asserted-by":"crossref","first-page":"1210","DOI":"10.1016\/j.ejca.2007.12.005","article-title":"Adjuvant dibromodulcitol and BCNU chemotherapy in anaplastic astrocytoma: Results of a randomised European Organisation for Research and Treatment of Cancer phase III study (EORTC study 26882)","volume":"44","author":"Hildebrand","year":"2008","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.ijrobp.2014.10.027_bib15","doi-asserted-by":"crossref","first-page":"5419","DOI":"10.1200\/JCO.2006.08.1497","article-title":"Significance of necrosis in grading of oligodendroglial neoplasms: A clinicopathologic and genetic study of newly diagnosed high-grade gliomas","volume":"24","author":"Miller","year":"2006","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ijrobp.2014.10.027_bib16","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1016\/j.hoc.2012.04.003","article-title":"Anaplastic gliomas: Radiation, chemotherapy, or both?","volume":"26","author":"Blondin","year":"2012","journal-title":"Hematol Oncol Clin North Am"},{"key":"10.1016\/j.ijrobp.2014.10.027_bib17","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1215\/15228517-2006-005","article-title":"Survival following adjuvant PCV or temozolomide for anaplastic astrocytoma","volume":"8","author":"Brandes","year":"2006","journal-title":"Neuro Oncol"},{"key":"10.1016\/j.ijrobp.2014.10.027_bib18","doi-asserted-by":"crossref","first-page":"5874","DOI":"10.1200\/JCO.2009.23.6497","article-title":"NOA-04 randomized phase III trial of sequential radiochemotherapy of anaplastic glioma with procarbazine, lomustine, and vincristine or temozolomide","volume":"27","author":"Wick","year":"2009","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ijrobp.2014.10.027_bib19","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1007\/s11060-010-0404-5","article-title":"Temozolomide during and after radiation therapy for WHO grade III gliomas: Preliminary report of a prospective multicenter study","volume":"103","author":"Kim","year":"2011","journal-title":"J Neurooncol"},{"key":"10.1016\/j.ijrobp.2014.10.027_bib20","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/j.radonc.2008.03.005","article-title":"Comparative evaluation of radiochemotherapy with temozolomide versus standard-of-care postoperative radiation alone in patients with WHO grade III astrocytic tumors","volume":"88","author":"Combs","year":"2008","journal-title":"Radiother Oncol J Eur Soc Ther Radiol Oncol"},{"key":"10.1016\/j.ijrobp.2014.10.027_bib21","doi-asserted-by":"crossref","first-page":"798","DOI":"10.1093\/neuonc\/nos081","article-title":"Radiotherapy and temozolomide in anaplastic astrocytoma: A retrospective multicenter study by the Central Nervous System Study Group of AIRO (Italian Association of Radiation Oncology)","volume":"14","author":"Scoccianti","year":"2012","journal-title":"Neuro Oncol"},{"key":"10.1016\/j.ijrobp.2014.10.027_bib22","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1016\/0360-3016(90)90096-3","article-title":"Superiority of post-radiotherapy adjuvant chemotherapy with CCNU, procarbazine, and vincristine (PCV) over BCNU for anaplastic gliomas: NCOG 6G61 final report","volume":"18","author":"Levin","year":"1990","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2014.10.027_bib23","doi-asserted-by":"crossref","first-page":"428","DOI":"10.3171\/jns.1992.76.3.0428","article-title":"Oligodendrogliomas: The Mayo Clinic experience","volume":"76","author":"Shaw","year":"1992","journal-title":"J Neurosurg"},{"key":"10.1016\/j.ijrobp.2014.10.027_bib24","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1007\/s11060-007-9370-y","article-title":"Prognosis in patients with anaplastic oligoastrocytoma is associated with histologic grade","volume":"84","author":"Buckner","year":"2007","journal-title":"J Neurooncol"},{"key":"10.1016\/j.ijrobp.2014.10.027_bib25","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1309\/6JNX4PA60TQ5U5VG","article-title":"Clarifying the diffuse gliomas: An update on the morphologic features and markers that discriminate oligodendroglioma from astrocytoma","volume":"124","author":"Gupta","year":"2005","journal-title":"Am J Clin Pathol"}],"container-title":["International Journal of Radiation Oncology*Biology*Physics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0360301614042977?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0360301614042977?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,8,19]],"date-time":"2019-08-19T15:25:21Z","timestamp":1566228321000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0360301614042977"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,2]]},"references-count":25,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2015,2]]}},"alternative-id":["S0360301614042977"],"URL":"https:\/\/doi.org\/10.1016\/j.ijrobp.2014.10.027","relation":{},"ISSN":["0360-3016"],"issn-type":[{"value":"0360-3016","type":"print"}],"subject":[],"published":{"date-parts":[[2015,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Impact of 1p\/19q Codeletion and Histology on Outcomes of Anaplastic Gliomas Treated With Radiation Therapy and Temozolomide","name":"articletitle","label":"Article Title"},{"value":"International Journal of Radiation Oncology*Biology*Physics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijrobp.2014.10.027","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}